Hyderabad, February 16, 2015 : Sapien Biosciences, a niche biotech venture backed by Apollo Hospitals, has entered into a collaboration with a Bangalore-based diagnostic start-up, OncoStem Diagnostics ...
BRIDGEWATER, N.J., June 27, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates ...
Sapien Biosciences leverages biobank resources to help validate and commercialise the novel test developed by OncoStem Diagnostics Sapien Biosciences, a niche biotech venture backed by Apollo ...
This collaboration aims to maximize the value of biobank data through AI-assisted harmonization, leading to precise patient outcomes at scale and lowering the cost of drug discovery. SAN FRANCISCO & ...
The US Food and Drug Administration (FDA) has approved the Sapien Transcatheter Heart Valve as the first percutaneously delivered artificial valve in the United States for use in patients with severe ...
Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback